ORKA Q4 2021 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$28,000

Operating Income

-$6M

Net Income

-$6M

EPS (Diluted)

$-4.73

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$55M

Total Liabilities

$4M

Stockholders' Equity

$51M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$28,000	-$16,000	-75.0%
Operating Income	-$6M	-$5M	-10.8%
Net Income	-$6M	-$5M	-10.8%